BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25304616)

  • 1. Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas.
    Fan X; Wang YY; Zhang CB; You G; Li MY; Wang L; Jiang T
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):729-34. PubMed ID: 25304616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
    Wang Y; Tang K; Zhao J; Liu L; Feng J
    Seizure; 2017 Nov; 52():41-45. PubMed ID: 28963932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas.
    Duan WC; Wang L; Li K; Wang WW; Zhan YB; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZY
    Medicine (Baltimore); 2018 Dec; 97(50):e13675. PubMed ID: 30558073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
    J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
    Wang Y; Fan X; Zhang W; Zhang C; Wang J; Jiang T; Wang L
    J Neurooncol; 2015 Feb; 121(3):609-16. PubMed ID: 25511798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
    Yao PS; Zheng SF; Wang F; Kang DZ; Lin YX
    J Neurosurg; 2018 Mar; 128(3):840-845. PubMed ID: 28387627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
    Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
    Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis.
    Li Y; Shan X; Wu Z; Wang Y; Ling M; Fan X
    Seizure; 2018 Feb; 55():76-82. PubMed ID: 29414139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients.
    Zhong Z; Wang Z; Wang Y; You G; Jiang T
    Epilepsy Res; 2015 Jan; 109():100-5. PubMed ID: 25524848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes and predictors of post-surgical seizures in patients with supratentorial low-grade gliomas.
    Jiang H; Liu B; Deng G; Yuan F; Tan Y; Yang K; Gao L; Wang J; Chen Q
    J Clin Neurosci; 2020 Feb; 72():163-168. PubMed ID: 31937499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis.
    Shan X; Fan X; Liu X; Zhao Z; Wang Y; Jiang T
    Neuro Oncol; 2018 Feb; 20(3):324-331. PubMed ID: 29016869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas.
    You G; Feng L; Yan W; Zhang W; Wang YZ; Li SW; Li SW; Li GL; Song YJ; Kang CS; You YP; Jiang T
    CNS Neurosci Ther; 2013 Nov; 19(11):882-8. PubMed ID: 23841872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.
    You G; Sha ZY; Yan W; Zhang W; Wang YZ; Li SW; Sang L; Wang Z; Li GL; Li SW; Song YJ; Kang CS; Jiang T
    Neuro Oncol; 2012 Feb; 14(2):230-41. PubMed ID: 22187341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
    Chang EF; Potts MB; Keles GE; Lamborn KR; Chang SM; Barbaro NM; Berger MS
    J Neurosurg; 2008 Feb; 108(2):227-35. PubMed ID: 18240916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study.
    Mazzucchi E; Vollono C; Pauletto G; Lettieri C; Budai R; Gigli GL; Sabatino G; La Rocca G; Skrap M; Ius T
    J Neurol; 2022 May; 269(5):2627-2633. PubMed ID: 34693462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control.
    Yuan Y; Xiang W; Yanhui L; Ruofei L; Shuang L; Yingjun F; Qiao Z; Yanwu Y; Qing M
    Seizure; 2013 Dec; 22(10):877-81. PubMed ID: 23992787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy surgery related to pediatric brain tumors: Miami Children's Hospital experience.
    Fallah A; Weil AG; Sur S; Miller I; Jayakar P; Morrison G; Bhatia S; Ragheb J
    J Neurosurg Pediatr; 2015 Dec; 16(6):675-80. PubMed ID: 26339959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
    Li L; Fang S; Li G; Zhang K; Huang R; Wang Y; Zhang C; Li Y; Zhang W; Zhang Z; Jin Q; Zhou D; Fan X; Jiang T
    J Neurosurg; 2022 Jan; 136(1):67-75. PubMed ID: 34243149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and mechanisms of epilepsy occurrence in cerebral gliomas: What to look for in clinicopathology.
    Huang C; Chi XS; Hu X; Chen N; Zhou Q; Zhou D; Li JM
    Exp Mol Pathol; 2017 Feb; 102(1):115-122. PubMed ID: 28087392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.
    Werner JM; Kuhl S; Stavrinou P; Röhn G; Krischek B; Blau T; Goldbrunner R; Timmer M
    Anticancer Res; 2017 Dec; 37(12):6639-6648. PubMed ID: 29187439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.